Home » China Awaits Achillion’s Antiviral Drug
China Awaits Achillion’s Antiviral Drug
New Haven drug developer Achillion Pharmaceuticals Inc. has licensed its treatment for
infectious blood disorders to a New Jersey bioscience company that will market the drug to China.
Hartford Business
Hartford Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May